115 related articles for article (PubMed ID: 36607721)
1.
Božina T; Karačić E; Ganoci L; Čuković-Čavka S; Palić J; Božina N; Šimičević L
Arh Hig Rada Toksikol; 2022 Dec; 73(4):303-307. PubMed ID: 36607721
[TBL] [Abstract][Full Text] [Related]
2. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V
Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142
[TBL] [Abstract][Full Text] [Related]
3. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
[TBL] [Abstract][Full Text] [Related]
4. Uridine diphosphate glucuronosyltransferase 2B7 variant p.His268Tyr as a predictor of kidney allograft early acute rejection.
Pazik J; Ołdak M; Lewandowski Z; Podgórska M; Sitarek E; Płoski R; Gałazka Z; Kwiatkowski A; Malejczyk J; Durlik M
Transplant Proc; 2013 May; 45(4):1516-9. PubMed ID: 23726609
[TBL] [Abstract][Full Text] [Related]
5. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.
Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG
Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162
[TBL] [Abstract][Full Text] [Related]
7. UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study.
Blanca Sánchez M; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolas JM; Adín J; Shushtarian M; Armijo JA
Ther Drug Monit; 2010 Apr; 32(2):177-84. PubMed ID: 20216122
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the Influence of UGT Genetic Polymorphisms on Lamotrigine Concentration.
Kim SC; Kim MG
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):163-169. PubMed ID: 30168665
[TBL] [Abstract][Full Text] [Related]
9. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B
Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
[TBL] [Abstract][Full Text] [Related]
11. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine.
Sawyer MB; Innocenti F; Das S; Cheng C; Ramírez J; Pantle-Fisher FH; Wright C; Badner J; Pei D; Boyett JM; Cook E; Ratain MJ
Clin Pharmacol Ther; 2003 Jun; 73(6):566-74. PubMed ID: 12811366
[TBL] [Abstract][Full Text] [Related]
12. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
13. CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.
Kwara A; Lartey M; Sagoe KW; Kenu E; Court MH
AIDS; 2009 Oct; 23(16):2101-6. PubMed ID: 19779319
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.
Saito K; Moriya H; Sawaguchi T; Hayakawa T; Nakahara S; Goto A; Arimura Y; Imai K; Kurosawa N; Owada E; Miyamoto A
Clin Biochem; 2006 Mar; 39(3):303-8. PubMed ID: 16466707
[TBL] [Abstract][Full Text] [Related]
15. Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia.
Sastre JA; Varela G; López M; Muriel C; González-Sarmiento R
Pain Pract; 2015 Jan; 15(1):22-30. PubMed ID: 24256307
[TBL] [Abstract][Full Text] [Related]
16. Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.
Jarrar YB; Cha EY; Seo KA; Ghim JL; Kim HJ; Kim DH; Lee SJ; Shin JG
J Lipid Res; 2014 Nov; 55(11):2334-42. PubMed ID: 25249502
[TBL] [Abstract][Full Text] [Related]
17. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
Yuan L; Qian S; Xiao Y; Sun H; Zeng S
Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
[TBL] [Abstract][Full Text] [Related]
18. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
Zhao M; Chen Y; Wang M; Li G; Zhao L
Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.
Bhasker CR; McKinnon W; Stone A; Lo AC; Kubota T; Ishizaki T; Miners JO
Pharmacogenetics; 2000 Nov; 10(8):679-85. PubMed ID: 11186130
[TBL] [Abstract][Full Text] [Related]
20. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.
Yang ZZ; Li L; Wang L; Yuan LM; Xu MC; Gu JK; Jiang HD; Yu LS; Zeng S
Acta Pharmacol Sin; 2017 Aug; 38(8):1184-1194. PubMed ID: 28552915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
